The US smallpox vaccination program : a review of a large modem era smallpox vaccination implementation programPOLAND, Gregory A; GRABENSTEIN, John D; NEFF, John M et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2078-2081, issn 0264-410X, 4 p.Conference Paper

The smallpox story: life and death of an old diseaseBEHBEHANI, A. M.Microbiological reviews. 1983, Vol 47, Num 4, pp 455-509, issn 0146-0749Article

An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategiesWISER, Itay; BALICER, Ran D; COHEN, Dani et al.Vaccine. 2007, Vol 25, Num 6, pp 976-984, issn 0264-410X, 9 p.Article

Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccinePHELPS, A. L; GATES, A. J; HILLIER, M et al.Vaccine. 2007, Vol 25, Num 1, pp 34-42, issn 0264-410X, 9 p.Article

Introduction : Simultaneously Global and Local: Reassessing Smallpox Vaccination and Its Spread, 1789-1900 = Introduction : Simultanément mondial et local : un réexamen de la vaccination contre la variole et de sa diffusion 1789-1900BHATTACHARYA, Sanjoy; BRIMNES, Niels.Bulletin of the history of medicine. 2009, Vol 83, Num 1, pp 1-16, issn 0007-5140, 16 p.Article

Smallpox. «Most terrible of all the ministers of death»MAGNER, L. N.International journal of dermatology. 1985, Vol 24, Num 7, pp 466-470, issn 0011-9059Article

Stability of diluted smallpox vaccine under simulated clinical conditionsKLINE, Richard L; REGNERY, Russell L; ARMSTRONG, Gregory L et al.Vaccine. 2005, Vol 23, Num 41, pp 4944-4946, issn 0264-410X, 3 p.Article

The introduction of variolation 'A La Turca' to the West by Lady Mary Montagu and Turkey's contribution to thisDINC, Gulten; ULMAN, Yesim Isil.Vaccine. 2007, Vol 25, Num 21, pp 4261-4265, issn 0264-410X, 5 p.Article

Priority, Invisibility and Eradication : The History of Smallpox and the Brazilian Public Health Agenda = L'histoire de la variole et le programme de santé publique brésilienHOCHMAN, Gilberto.Medical history. 2009, Vol 53, Num 2, pp 229-252, issn 0025-7273, 24 p.Article

Pocken: Klinik, Therapie und Anästhesiologische Aspekte (Teil 1) = Small pox: Infection, therapy and anaesthesiological management (Part 1)LANGEFELD, T. W; ENGEL, J; MENGES, T et al.AINS. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 2003, Vol 38, Num 7, pp 445-455, issn 0939-2661, 11 p.Article

Pregnancy discovered after smallpox vaccination: Is vaccinia immune globulin appropriate?NAPOLITANO, Peter G; RYAN, Margaret A. K; GRABENSTEIN, John D et al.American journal of obstetrics and gynecology. 2004, Vol 191, Num 6, pp 1863-1867, issn 0002-9378, 5 p.Article

Daniel Bernoulli's epidemiological model revisitedDIETZ, Klaus; HEESTERBEEK, J. A. P.Mathematical biosciences. 2002, Vol 180, pp 1-21, issn 0025-5564, 21 p.Article

Contact spread of vaccinia from a recently vaccinated marine-LouisianaClinical pediatrics. 1984, Vol 23, Num 10, issn 0009-9228, 592Article

VARIOLE : VIH, GRIPPE, PALUDISME, EBOLIA... UN MONDE D'ÉPIDÉMIESVERNET, Agnès.Biofutur (Puteaux). 2013, Num 348, pp 28-29, issn 0294-3506, 2 p.Article

Pre-event smallpox vaccination for healthcare workers revisited- : the need for a carefully screened multidisciplinary cadreMALONE, John D.International journal of infectious diseases. 2007, Vol 11, Num 2, pp 93-97, issn 1201-9712, 5 p.Article

Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5PORTOCARRERO, Carla; MARKLEY, Karen; KOPROWSKI, Hilary et al.Vaccine. 2008, Vol 26, Num 43, pp 5535-5540, issn 0264-410X, 6 p.Article

A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteersJANG, Hee-Chang; CHOONG JONG KIM; KIM, Hong-Bin et al.Vaccine. 2010, Vol 28, Num 36, pp 5845-5849, issn 0264-410X, 5 p.Article

Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus disseminationGROSENBACH, Douglas W; JORDAN, Robert; HRUBY, Dennis E et al.Vaccine. 2008, Vol 26, Num 7, pp 933-946, issn 0264-410X, 14 p.Article

Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines : Scarification vaccinationJENTARRA, Garilyn M; HECK, Michael C; JIN WON YOUN et al.Vaccine. 2008, Vol 26, Num 23, pp 2860-2872, issn 0264-410X, 13 p.Article

Reactions to small pox vaccine in naive and previously-vaccinated individualsAUCKLAND, Cressida; COWLISHAW, Alexandra; MORGAN, Dilys et al.Vaccine. 2005, Vol 23, Num 32, pp 4185-4187, issn 0264-410X, 3 p.Article

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE^®VON KREMPELHUBER, Alfred; VOLLMAR, Jens; CHAPLIN, Paul et al.Vaccine. 2010, Vol 28, Num 5, pp 1209-1216, issn 0264-410X, 8 p.Article

An open-label, single arm, phase III clinical study to evaluate the efficacy and safety of CJ smallpox vaccine in previously vaccinated healthy adultsKIM, Nak-Hyun; YU MIN KANG; KIM, Gayeon et al.Vaccine. 2013, Vol 31, Num 45, issn 0264-410X, S239-S242Article

Comparative efficacy of replicating smallpox vaccine strains in a Murine Challenge ModelPHELPS, A; GATES, A. J; HILLIER, M et al.Vaccine. 2005, Vol 23, Num 27, pp 3500-3507, issn 0264-410X, 8 p.Article

Towards universal childhood immunization : Why we must and how we mightMUSIC, Stanley.Vaccine. 2005, Vol 23, Num 48-49, pp 5474-5477, issn 0264-410X, 4 p.Article

Biological agents with potential for misuse: a historical perspective and defensive measuresBHALLA, Deepak K; WARHEIT, David B.Toxicology and applied pharmacology. 2004, Vol 199, Num 1, pp 71-84, issn 0041-008X, 14 p.Article